检索结果 - Parviz Ghahramani
- Showing 1 - 7 results of 7
-
1
-
2
-
3
-
4
Phase II Study of Efficacy, Safety, and Pharmacokinetics of Trastuzumab Monotherapy Administered on a 3-Weekly Schedule 由 José Baselga, Xavier Carbonell, Noel-Jaime Castañeda-Soto, Michael Clemens, Michael Green, Vernon Harvey, Serafín Morales, Claire Barton, Parviz Ghahramani
出版 2005Artigo -
5
-
6
-
7
Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [11C]-(+)-PHNO 由 Ragy R. Girgis, Mark Slifstein, Deepak Cyril D’Souza, Yih Lee, Antonia Periclou, Parviz Ghahramani, I. Laszlovszky, Suresh Durgam, Nika Adham, Nabeel Nabulsi, Yiyun Huang, Richard E. Carson, Béla Kiss, Margit Kapás, Anissa Abi‐Dargham, Ashok Rakhit
出版 2016Artigo
相关主题
Medicine
Internal medicine
Pharmacokinetics
Pharmacology
Adverse effect
Breast cancer
Cancer
Engineering
Gastroenterology
Law
Oncology
Pathology
Political science
Psychiatry
Trastuzumab
Alternative medicine
Anesthesia
Antifungal
Bioavailability
Biochemical engineering
Bioequivalence
Biology
Biopharmaceutical
Biopharmaceutics Classification System
Biotechnology
Business
Chemistry
Chemotherapy
Cisplatin
Cohort